Monique Cho
Physician · University of Utah School of Medicine
Credentials: · · ·
History
Research
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
Nature Genetics · 2008 · 554 citations
Pirfenidone for diabetic nephropathy
Journal of the American Society of Nephrology · 2011 · 254 citations
Urinary exosomal transcription factors, a new class of biomarkers for renal disease
Kidney International · 2008 · 206 citations
- JK
10 papers
8 papers
4 papers
3 papers
3 papers
3 papers
3 papers
3 papers
Grants
- 2026–2029
The Effects of SGLT2 Inhibition on Vascular Health and Physical Function in Veterans with CKD
Department of Veterans Affairs · I01
Contact PI · Va Salt Lake City Healthcare System
- 2022–2027
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-Dependent ESKD
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $910.7K · Utah State Higher Education System--University of Utah
- 2018–2024
The Role of Functional Iron Deficiency in Systemic Complications of CKD
Department of Veterans Affairs · I01
Contact PI · Va Salt Lake City Healthcare System
Clinical trials
- 2026–2029
Vascular Effects of SGLT2i in Non-diabetic CKD
Principal investigator · Not yet recruiting · Phase 2
VA Office of Research and Development
- 2004–2012
Principal investigator · Completed · Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2003–2014
Kidney Transplantation in Patients With Cystinosis
Principal investigator · Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2003–2014
Principal investigator · Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)